GenMont Biotech, Ewelle Biomedical Share Exchange Case: Strong Bio-Pharmaceutical Withdraws Urgent Disposition Application
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Genovate announced on May 11 that shareholder Johnson Chemical has withdrawn its petition for an emergency injunction regarding Genovate's proposed share swap with EirGenix. However, Johnson Chemical's parallel application for a provisional injunction against the deal, which was approved by shareholders on April 22, remains under court review.